PubRank
Search
About
Jessica B S Langbaum
Author PubWeight™ 33.47
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
Proc Natl Acad Sci U S A
2009
5.55
2
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
Lancet Neurol
2012
3.48
3
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.
J Alzheimers Dis
2011
2.78
4
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
Lancet Neurol
2012
2.65
5
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.
Neuroimage
2010
2.29
6
Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.
Biomark Med
2010
2.17
7
Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups.
Neuroimage
2009
1.89
8
Training and maintaining memory abilities in healthy older adults: traditional and novel approaches.
J Gerontol B Psychol Sci Soc Sci
2007
1.81
9
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.
JAMA Neurol
2013
1.75
10
Characterizing Alzheimer's disease using a hypometabolic convergence index.
Neuroimage
2011
1.54
11
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
J Clin Psychiatry
2014
1.25
12
Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
Neuroimage
2009
1.17
13
Modeling change in memory performance and memory perceptions: findings from the ACTIVE study.
Psychol Aging
2011
0.92
14
Memory training in the ACTIVE study: how much is needed and who benefits?
J Aging Health
2012
0.88
15
Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers.
Neuroimage
2010
0.86
16
Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability.
J Int Neuropsychol Soc
2012
0.85
17
Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Neuroimage
2012
0.85
18
Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose.
PLoS One
2013
0.84
19
Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.
J Neurosci Methods
2010
0.82